|Mr. Gagandeep Singh Bedi||MD & Exec. Director||N/A||N/A||46|
|Mr. Rajesh Marwaha||CFO & Whole Time Director||4.09M||N/A||54|
|Mr. Pratap B. Rudra||Legal Counsel, Compliance Officer & Company Sec.||807.41k||N/A||N/A|
|Mrs. Smita Saha||VP of HR||N/A||N/A||47|
|Mr. Sanjeev Panchal||Bus. Unit Head - ACS||N/A||N/A||40|
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It operates in two segments, Healthcare and Others. The company offers products in the areas of cardiovascular and metabolic, oncology, neuroscience, and gastrointestinal, as well as respiratory, inflammation, and autoimmunity diseases; and infection and vaccine products under the Brilinta, Betaloc, Seloken XL, Imdur, Crestor, Forxiga, Onglyza, Kombiglyze XR, Byetta, Symbicort, Arimidex, Nolvadex, Iressa, Zoladex, Casodex, Faslodex, and Tagrisso brands. It also provides clinical trial services on pharmaceutical products. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca PLC.
AstraZeneca Pharma India Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.